Vanderbilt University Medical Center - MEND Clinic
Nashville, Tennessee, 37212, United States
NCT Number: NCT02339935
This study aims to implement and test a specific brief Applied Behavior Analysis model for assessing and responding to severe challenging behavior during acute medical and behavioral hospitalization for children with ASD. The investigators will evaluate the impact of this program by conducting a randomized trial across both medical and psychiatric hospital settings.
Looking for future studies?
Notify Me6 year–18 year
All sexes
Interventional
Not applicable
Nashville, Tennessee, 37212, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Brief AFA seeks to identify the function of the challenging behavior by creating controlled test conditions in which specific responses are provided for challenging behavior (e.g., attention, escape from task demands, access to tangible - including variants of each as needed), as well as a control condition in which continual access to attention and preferred items is provided. It consists of a 30-90-minute abbreviated analysis comprised of a single exposure to 2-5-minute test and control conditions, along with replication of applicable test conditions and a treatment probe, which provides evidence of challenging behavior function faster than other methods.
These participants will receive typical standard of care procedures while hospitalized, but will not receive the additional behavioral intervention
Time frame: Change from Baseline ABC at Hospital Discharge (an expected average of 42 days) and 3-Months Post-Discharge
The ABC is a well-validated measure designed to assess for the presence of clinically significant challenging behavior in the areas of irritability and agitation, lethargy and social withdrawal, stereotypic behavior, hyperactivity and noncompliance, and inappropriate speech.
Time frame: Participants will be followed from admission to discharge, an expected average of 42 days
Reduction in the days hospitalized past medical clearance).
Time frame: Baseline and Day of Patient's Discharge (an expected average of 42 days from admission)
Attending physician's impressions of participant's clinical impairment and improvement.
Time frame: Participants will be followed for duration of hospital stay, an expected average of 42 days
Blinded coding of the challenging behaviors targeted in the treatment arm
Time frame: Day of Patient's Discharge (an expected average of 42 days from admission)
The primary medical attending, lead discharge nurse staff member, and the child's primary parent will also be asked at discharge to provide both quantitative and qualitative ratings of challenges and successes during hospitalization. Caregivers will be contacted to complete a simple interview/questionnaire 3- months post-hospitalization regarding changes in the patient's medication, medical conditions, residential/classroom placement, emergency room visits or psychiatric hospitalizations since the discharge date, as well as ratings of successes implementing components of the behavioral strategies plan utilized during the hospitalization (if applicable).
Vanderbilt University
Other
Improving Hospitalizations for Children With ASD: Testing the Cost and Clinical Efficacy of Integrated Behavioral Intervention
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04788537
Asperger Syndrome, Autism
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT03170453
Asperger Syndrome, Autism Spectrum Disorder
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT04475848
Autism Spectrum Disorder, Autistic Disorder
London, United Kingdom
View Trial DetailsNCT05453708
Autism, Autism Spectrum Disorder
Minneapolis, Minnesota, United States
View Trial Details